Curcucubin will have a global market capitalisation of $84 million, with CAGR over 11%
-
Last Update: 2021-02-15
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
according to market research
The global
will continue to grow steadily over the forecast period, according to a research report by Credence Research. Curcucubin is
expected to have a global market capitalisation of $
84 million
by
2022, from
2015
to
2022
CAGR
11.6%
in
, while
had a market capitalization of $
30 million
in
.
the therapeutic properties of curcutin in anti-inflammatory and antioxidant applications make it ideal for use in the food and medical fields. For example, the advantages of curcutin in inhibiting the growth of Helicobacterrobacteria increase the demand for nutritional supplements for the treatment of stomach ulcers and stomach cancers.With the increase of consumer awareness of the above therapeutic properties, the market prospects for curcub are also bright. The growing consumer demand for herbs and Ayurvedic skin care products has also led to better development of curcubin during this period. Curcub and curcub extracts, which are mainly used in the field of food products, have also gained more attention due to their low bio-utilization.In addition, the demand for curculin in pharmaceuticals has increased significantly due to the need for
OTC
drugs in more than
50% of the world's
regions. Consumers' preference for natural pigments and flavorings has increased significantly since2014 in the demand for curcumin in food applications. The increasing penetration of curcubin in the field of herbal skin care has also increased its market demand.It is understood that due to the increased demand
for curcub in Europe, the curcuculin market
CAGR
is expected to exceed
17%
between
2015 and
2022
. The watchdog also believes that increased consumer awareness of this health component has also been a key factor in the rise in sales of the product. In addition,
EFSA
has approved a per capita intake standard of
3
mg
/
kg body weight for curcuculin, and its application as a pharmaceutical ingredient has also been one of the reasons for the increased demand for curcub in the market., drug applications account for the major market share of curcucutin globally, and food is the second largest market for curcucutin applications. Other applications, such as cyanide detection and dyes, are expected to boost market growth in the near future.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.